We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Deoxyribozyme Strategy Applied to Infectious Pathogen Detection

By LabMedica International staff writers
Posted on 14 Mar 2013
A novel strategy has integrated two emerging technologies for point-of-care (POC) analysis of infectious disease targets.

The combination of colorimetric coupling of surface plasmons of gold nanoparticles with deoxyribozymes (DNAzyme) signal amplification technology creates a fast and simple detection method for genetic targets with a simple colorimetric readout.

Scientists at the University of Toronto (ON, Canada) have generated a rapid-diagnostic biosensor that will allow technicians to test for multiple diseases at one time with one small sample, and with high accuracy and sensitivity. More...
The biosensor relies upon gold particles in much the same vein as the average pregnancy test. With a pregnancy test, gold particles turn the test window red because the particles are linked with an antigen that detects a certain hormone in the urine of a pregnant woman.

The scientists can target a particular disease by linking gold particles with DNA strands. When a sample containing the disease gene, such as malaria, is present, it clumps the gold nanoparticles (GNP), turning the sample blue. Rather than clumping the particles together, the team immerses the gold particles in a DNA-based enzyme solution (DNAzyme) that, when the disease gene is introduced, snips the DNA from the gold particles, turning the sample red. The linker strand includes a substrate sequence that can be cleaved by a multicomponent nucleic acid enzyme (MNAzyme), which is one of the reported DNA responsive DNAzymes.

The advantage of this method is that far less of the gene needs to be present for the solution to show noticeable color changes, amplifying detection. A single DNAzyme can snip up to 600 “links” between the target genes. Just a single drop from a biological sample such as saliva or blood can potentially be tested in parallel, so that multiple diseases can be tested in one sitting. The team has also demonstrated that they can transform the testing solution into a powder, making it light and far easier to ship than solutions, which degrade over time. Powder can be stored for years at a time, and offers hope that the technology can be developed into efficient, cheap, over-the-counter tests for diseases such as Human immunodeficiency virus (HIV) and malaria for developing countries, where access to portable diagnostics is a necessity

Warren Chan, PhD, the senior author of the study, who holds a Canada Research Chair in Nanobiotechnology, said, "There's been a lot of emphasis in developing simple diagnostics. The question is how do you make it simple enough, portable enough? Gold is the best medium, because it's easy to see. It emits a very intense color." The authors concluded the MNAzyme-GNP assay provides a simple and fast colorimetric method for detection of genetic targets of bacterial, viral, and parasitic origins with 50 pM sensitivity without the need for purification and separation steps. The study was published online on February 10, 2013, in the journal Angewandte Chemie International Edition.

Related Links:
University of Toronto



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Gold Member
Pipette Management Software
VIALINK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.